Lung Cancer 2024 REVIEW

Lung Cancer 2024 REVIEW

LUNG CANCER 2024 REVIEW Druggable since 2024: an overview of newly approved therapies for NSCLC Solange Peters Highlights of the year in targeted therapies Jordi Remon Highlights of the year in immunotherapies Hossein Borghaei  } 1 h 43 min Get Your CME...
EARLY NSCLC

EARLY NSCLC

EARLY NSCLC Welcome & introduction by host Jean Yannis Perentes To resect, or not to resect in early NSCLC: the who, when and how in thoracic surgery Jonathan Spicer The multidimensional role of radiotherapy in stage III NSCLC Salma Jabbour Transforming early NSCLC...